BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 1840201)

  • 21. Renal effects of calcium antagonists with special reference to manidipine hydrochloride.
    Rodicio JL
    Blood Press Suppl; 1996; 5():10-5. PubMed ID: 8973787
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nitrendipine reverses vasoconstriction and renal hemodynamic changes in experimental hypertension.
    Sterzel RB; Huelsemann JL; McKenzie DE; Wilcox CS
    J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S1024-7. PubMed ID: 6085360
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of cardiovascular, renal, and humoral effects of acute administration of two calcium channel blockers in normotensive and hypertensive subjects.
    Leonetti G; Cuspidi C; Sampieri L; Terzoli L; Zanchetti A
    J Cardiovasc Pharmacol; 1982; 4 Suppl 3():S319-24. PubMed ID: 6184561
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of the antiproteinuric effects of the calcium channel blockers benidipine and amlodipine administered in combination with angiotensin receptor blockers to hypertensive patients with stage 3-5 chronic kidney disease.
    Abe M; Okada K; Maruyama T; Maruyama N; Matsumoto K
    Hypertens Res; 2009 Apr; 32(4):270-5. PubMed ID: 19262495
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Slow release nifedipine in treatment of hypertension. 24-hour effect on blood pressure and heart rate--treatment follow-up of 391 patients].
    Bühler G; Wadepuhl M; Nandi K; Rosenthal J
    Fortschr Med; 1997 Aug; 115(24):37-8. PubMed ID: 9410819
    [No Abstract]   [Full Text] [Related]  

  • 26. [Effects of intravenous nicardipine hydrochloride (YC 93), a calcium antagonist, on renal function (author's transl)].
    Yokoyama S; Kaburagi T
    Nihon Jinzo Gakkai Shi; 1981 Aug; 23(8):1143-51. PubMed ID: 7321319
    [No Abstract]   [Full Text] [Related]  

  • 27. A randomized and double-blind comparison of isradipine and spirapril as monotherapy and in combination on the decline in renal function in patients with chronic renal failure and hypertension.
    Petersen LJ; Petersen JR; Talleruphuus U; Møller ML; Ladefoged SD; Mehlsen J; Jensen HA
    Clin Nephrol; 2001 May; 55(5):375-83. PubMed ID: 11393383
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Renal and haemodynamic effects of amlodipine and nifedipine in hypertensive renal transplant recipients.
    Venkat-Raman G; Feehally J; Elliott HL; Griffin P; Moore RJ; Olubodun JO; Wilkinson R
    Nephrol Dial Transplant; 1998 Oct; 13(10):2612-6. PubMed ID: 9794569
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Comparative study to assess the efficacy and adverse effects of amlodipine and nifedipine retard in patients with stable exertional angina and hypertension].
    Witkowska M; Tracz W; Kubler G; Negrusz-Kawecka M; Hlawaty M; Olszowska M; Salamon P
    Przegl Lek; 1997; 54(5):324-8. PubMed ID: 9380807
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of strict blood pressure control by a long-acting calcium channel blocker on brain natriuretic peptide and urinary albumin excretion rate in Japanese hypertensive patients.
    Uno H; Ishikawa J; Hoshide S; Kabutoya T; Ishikawa S; Shimada K; Kario K
    Hypertens Res; 2008 May; 31(5):887-96. PubMed ID: 18712044
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of changes in sympathetic nerve activity and heart rate in essential hypertensive patients induced by amlodipine and nifedipine.
    Hamada T; Watanabe M; Kaneda T; Ohtahara A; Kinugawa T; Hisatome I; Fujimoto Y; Yoshida A; Shigemasa C
    J Hypertens; 1998 Jan; 16(1):111-8. PubMed ID: 9533424
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Renal effects of the calcium channel blocker aranidipine and its active metabolite in anesthetized dogs and conscious spontaneously hypertensive rats.
    Ichihara K; Okumura K; Kamei H; Nagasaka M; Kanda A; Kanno T; Miyoshi K; Miyake H
    J Cardiovasc Pharmacol; 1998 Feb; 31(2):277-85. PubMed ID: 9475270
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A dose-response study of amlodipine in mild to moderate hypertension.
    Frick MH; McGibney D; Tyler HM
    J Intern Med; 1989 Feb; 225(2):101-5. PubMed ID: 2522134
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cardiovascular and renal effects of single administration of three different doses of isradipine in hypertensive patients. Dose-response curves of the different effects.
    Rupoli L; Fruscio M; Gradnik R; Chianca R; Leonetti G; Zanchetti A
    Am J Med; 1989 Apr; 86(4A):65-6. PubMed ID: 2523658
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of the two new calcium channel blockers mebudipine and dibudipine in comparison to amlodipine on vascular flow of isolated kidney of diabetic rat.
    Sepehr-Ara L; Sepehr-Ara M; Mahmoudian M
    Acta Physiol Hung; 2010 Sep; 97(3):281-9. PubMed ID: 20843766
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acute antihypertensive and renal effects of isradipine in hypertensive patients with normal and reduced renal function.
    Wittenberg C; Rosenfeld JB
    Am J Hypertens; 1991 Feb; 4(2 Pt 2):191S-193S. PubMed ID: 1827019
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The clinical efficacy of the calcium antagonist amlodipine in patients with ischemic heart disease and arterial hypertension].
    Zviagina TV
    Lik Sprava; 2000; (5):114-7. PubMed ID: 11031470
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of nifedipine on renal function in patients with essential hypertension.
    Reams GP; Hamory A; Lau A; Bauer JH
    Hypertension; 1988 May; 11(5):452-6. PubMed ID: 3366479
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [24-hour protection and control: a new era of calcium antagonists. Amlodipine provides 24 hours of efficacy and safety].
    Med Clin (Barc); 1992 Feb; 98(8):suppl 2 p.. PubMed ID: 1532845
    [No Abstract]   [Full Text] [Related]  

  • 40. The effect of nisoldipine on renal function in the long-term treatment of hypertension in patients with and without renal impairment.
    Wilson J; Wahbha MM; Martin PG; Hainsworth R; Brownjohn AM; Turney JH; Davies JA; Prentice CR
    Eur J Clin Pharmacol; 1989; 37(5):437-41. PubMed ID: 2689184
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.